GLUT1 Biological Function and Inhibition: Research Advances

References

• Ferreira LM . Cancer metabolism: the Warburg effect today. Exp. Mol. Pathol.89(3), 372–380 (2010).
   PubMed Web of Science ®Google Scholar
• Abdou AG , EldienMM , ElsakkaD. GLUT-1 expression in cutaneous basal and squamous cell carcinomas. Int. J. Surg. Pathol.23(6), 447–453 (2015).
   PubMed Web of Science ®Google Scholar
• Ancey PB , ContatC , MeylanE. Glucose transporters in cancer – from tumor cells to the tumor microenvironment. FEBS. J.285(16), 2926–2943 (2018).
   PubMed Web of Science ®Google Scholar
• Ma X , HuiY , LinLet al. Clinical significance of COX-2, GLUT-1 and VEGF expressions in endometrial cancer tissues. Pak. J. Med. Sci.31(2), 280–284 (2015).
   PubMed Web of Science ®Google Scholar
• Qamar S , FatimaS , RehmanAet al. Glucose transporter 1 overexpression in oral squamous cell carcinoma. J. Coll. Physicians Surg. Pak.29(8), 724–727 (2019).
   PubMed Web of Science ®Google Scholar
• Mueckler M , ThorensB. The SLC2 (GLUT) family of membrane transporters. Mol. Aspects Med.34(2–3), 121–138 (2013).
   PubMed Web of Science ®Google Scholar
• Carruthers A , DezutterJ , GangulyA , DevaskarSU. Will the original glucose transporter isoform please stand up. Am. J. Physiol. Endocrinol. Metab.297(4), E836–848 (2009).
   PubMed Web of Science ®Google Scholar
• Uldry M , IbbersonM , HosokawaM , ThorensB. GLUT2 is a high affinity glucosamine transporter. FEBS Lett.524(1–3), 199–203 (2002).
   PubMed Web of Science ®Google Scholar
• Reckzeh ES , WaldmannH. Development of glucose transporter (GLUT) inhibitors. Eur. J. Org. Chem.2020(16), 2321–2329 (2020).
   PubMed Web of Science ®Google Scholar
• Uldry M , ThorensB. The SLC2 family of facilitated hexose and polyol transporters. Pflugers. Arch.447(5), 480–489 (2004).
   PubMed Web of Science ®Google Scholar
• Joost HG , ThorensB. The extended GLUT-family of sugar/polyol transport facilitators: nomenclature, sequence characteristics, and potential function of its novel members (review). Mol. Membr. Biol.18(4), 247–256 (2001).
   PubMed Web of Science ®Google Scholar
• Caulfield MJ , MunroePB , O'NeillDet al. SLC2A9 is a high-capacity urate transporter in humans. PLoS Med.5(10), e197 (2008).
   PubMed Web of Science ®Google Scholar
• Deng D , XuC , SunPet al. Crystal structure of the human glucose transporter GLUT1. Nature510(7503), 121–125 (2014).
   PubMed Web of Science ®Google Scholar
• Graybill C , Van HoekAN , DesaiDet al. Ultrastructure of human erythrocyte GLUT1. Biochemistry45(26), 8096–8107 (2006).
   PubMed Web of Science ®Google Scholar
• Zottola RJ , ClohertyEK , CoderrePEet al. Glucose transporter function is controlled by transporter oligomeric structure. A single, intramolecular disulfide promotes GLUT1 tetramerization. Biochemistry34(30), 9734–9747 (1995).
   PubMed Web of Science ®Google Scholar
• De Zutter JK , LevineKB , DengD , CarruthersA. Sequence determinants of GLUT1 oligomerization: analysis by homology-scanning mutagenesis. J. Biol. Chem.288(28), 20734–20744 (2013).
   PubMed Web of Science ®Google Scholar
• Lloyd KP , OjelabiOA , DeZutter JK , CarruthersA. Reconciling contradictory findings: glucose transporter 1 (GLUT1) functions as an oligomer of allosteric, alternating access transporters. J. Biol. Chem.292(51), 21035–21046 (2017).
   PubMed Web of Science ®Google Scholar
• Hamill S , ClohertyEK , CarruthersA. The human erythrocyte sugar transporter presents two sugar import sites. Biochemistry38(51), 16974–16983 (1999).
   PubMed Web of Science ®Google Scholar
• Baker GF , NaftalinRJ. Evidence of multiple operational affinities for D-glucose inside the human erythrocyte membrane. Biochim. Biophys. Acta.550(3), 474–484 (1979).
   PubMedGoogle Scholar
• Naftalin RJ . Reassessment of models of facilitated transport and cotransport. J. Membr. Biol.234(2), 75–112 (2010).
   PubMed Web of Science ®Google Scholar
• Tian Y , ShenS , GuLet al. Computer-aided design of glucoside brain-targeted molecules based on 4PYP. J. Mol. Graph. Model103, 107819 (2020).
   PubMed Web of Science ®Google Scholar
• Simpson IA , DwyerD , MalideDet al. The facilitative glucose transporter GLUT3: 20 years of distinction. Am. J. Physiol-Endoc. M.295(2), E242–E253 (2008).
   PubMed Web of Science ®Google Scholar
• Huang S , CzechMP. The GLUT4 glucose transporter. Cell Metab.5(4), 237–252 (2007).
   PubMed Web of Science ®Google Scholar
• Chen C , PoreN , BehroozAet al. Regulation of glut1 mRNA by hypoxia-inducible factor-1. Interaction between H-ras and hypoxia. J. Biol. Chem.276(12), 9519–9525 (2001).
   PubMed Web of Science ®Google Scholar
• Weinstein SP , HaberRS. Glucose transport stimulation by thyroid hormone in ARL 15 cells: partial role of increased GLUT1 glucose transporter gene transcription. Thyroid3(2), 135–142 (1993).
   PubMed Web of Science ®Google Scholar
• Schwartzenberg-Bar-Yoseph F , ArmoniM , KarnieliE. The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression. Cancer Res.64(7), 2627–2633 (2004).
   PubMed Web of Science ®Google Scholar
• Cifuentes M , GarciaMA , ArrabalPMet al. Insulin regulates GLUT1-mediated glucose transport in MG-63 human osteosarcoma cells. J. Cell Physiol.226(6), 1425–1432 (2011).
   PubMed Web of Science ®Google Scholar
• Tan VP , MiyamotoS. HK2/hexokinase-II integrates glycolysis and autophagy to confer cellular protection. Autophagy11(6), 963–964 (2015).
   PubMed Web of Science ®Google Scholar
• Angira D , NatarajanN , DedaniaSRet al. Characterization of P. aeruginosa glucose 6-phosphate isomerase: a functional insight via in-vitro activity study. Curr. Top. Med. Chem.20(29), 2651–2661 (2020).
   PubMed Web of Science ®Google Scholar
• Webb BA , ForouharF , SzuFEet al. Structures of human phosphofructokinase-1 and atomic basis of cancer-associated mutations. Nature523(7558), 111–114 (2015).
   PubMed Web of Science ®Google Scholar
• White MR , GarcinED. D-glyceraldehyde-3-phosphate dehydrogenase structure and function. Sub-Cell. Biochem.83, 413–453 (2017).
   PubMedGoogle Scholar
• Fu Q , YuZ. Phosphoglycerate kinase 1 (PGK1) in cancer: a promising target for diagnosis and therapy. Life Sci.256, 117863 (2020).
   PubMed Web of Science ®Google Scholar
• Sharif F , RasulA , AshrafAet al. Phosphoglycerate mutase 1 in cancer: a promising target for diagnosis and therapy. IUBMB Life71(10), 1418–1427 (2019).
   PubMed Web of Science ®Google Scholar
• Counihan JL , GrossmanEA , NomuraDK. Cancer metabolism: current understanding and therapies. Chem. Rev.118(14), 6893–6923 (2018).
   PubMed Web of Science ®Google Scholar
• Ashton TM , McKennaWG , Kunz-SchughartLA , HigginsGS. Oxidative phosphorylation as an emerging target in cancer therapy. Clin. Cancer Res.24(11), 2482–2490 (2018).
   PubMed Web of Science ®Google Scholar
• Reckzeh ES , WaldmannH. Small-molecule inhibition of glucose transporters GLUT-1–4. Chembiochem21(1), 45–52 (2020).
   PubMed Web of Science ®Google Scholar
• Yin C , GaoB , YangJ , WuJ. Glucose transporter-1 (GLUT-1) expression is associated with tumor size and poor prognosis in locally advanced gastric cancer. Med. Sci. Monit. Basic Res.26, e920778 (2020).
   PubMed Web of Science ®Google Scholar
• Zhao M , ZhangZ. Glucose transporter regulation in cancer: a profile and the loops. Crit. Rev. Eukaryot Gene. Expr.26(3), 223–238 (2016).
   PubMed Web of Science ®Google Scholar
• Zhou JC , ZhangJJ , ZhangWet al. Expression of GLUT-1 in nasopharyngeal carcinoma and its clinical significance. Eur. Rev. Med. Pharmacol. Sci.21(21), 4891–4895 (2017).
   PubMed Web of Science ®Google Scholar
• Zhou L , LiS , LiuLet al. Recombinant methioninase regulates PI3K/Akt/Glut-1 pathway and inhibits aerobic glycolysis to promote apoptosis of gastric cancer cells. Nan Fang Yi Ke Da Xue Xue Bao40(1), 27–33 (2020).
   PubMedGoogle Scholar
• National Cancer Institute . Cancer Stat Facts 2019. (2020). https://seer.cancer.gov/statfacts/html/corp.html
   Google Scholar
• Rudlowski C , MoserM , BeckerAJet al. GLUT1 mRNA and protein expression in ovarian borderline tumors and cancer. Oncology66(5), 404–410 (2004).
   PubMed Web of Science ®Google Scholar
• Xintaropoulou C , WardC , WiseAet al. Expression of glycolytic enzymes in ovarian cancers and evaluation of the glycolytic pathway as a strategy for ovarian cancer treatment. BMC Cancer18(1), 636 (2018).
   PubMedGoogle Scholar
• Ozcan A , ShenSS , ZhaiQJ , TruongLD. Expression of GLUT1 in primary renal tumors: morphologic and biologic implications. Am. J. Clin. Pathol.128(2), 245–254 (2007).
   PubMed Web of Science ®Google Scholar
• Stower H . Tracing clear cell renal carcinoma evolution. Nat. Med.24(6), 702 (2018).
   Web of Science ®Google Scholar
• Almeida L , SilvaR , CavadasBet al. GLUT1, MCT1/4 and CD147 overexpression supports the metabolic reprogramming in papillary renal cell carcinoma. Histol Histopathol32(10), 1029–1040 (2017).
   PubMed Web of Science ®Google Scholar
• Amann T , MaegdefrauU , HartmannAet al. GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis. Am. J. Pathol.174(4), 1544–1552 (2009).
   PubMed Web of Science ®Google Scholar
• Sun HW , YuXJ , WuWCet al. GLUT1 and ASCT2 as predictors for prognosis of hepatocellular carcinoma. PLoS ONE11(12), e0168907 (2016).
   PubMed Web of Science ®Google Scholar
• Nishioka T , OdaY , SeinoYet al. Distribution of the glucose transporters in human brain tumors. Cancer Res.52(14), 3972–3979 (1992).
   PubMed Web of Science ®Google Scholar
• Brown RS , WahlRL. Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study. Cancer72(10), 2979–2985 (1993).
   PubMed Web of Science ®Google Scholar
• Shen YM , ArbmanG , OlssonB , SunXF. Overexpression of GLUT1 in colorectal cancer is independently associated with poor prognosis. Int. J. Biol. Markers26(3), 166–172 (2011).
   PubMed Web of Science ®Google Scholar
• Sasaki H , ShitaraM , YokotaKet al. Overexpression of GLUT1 correlates with Kras mutations in lung carcinomas. Mol. Med. Rep.5(3), 599–602 (2012).
   PubMed Web of Science ®Google Scholar
• Reinicke K , SotomayorP , CisternaP , DelgadoC , NualartF , GodoyA. Cellular distribution of Glut-1 and Glut-5 in benign and malignant human prostate tissue. J. Cell Biochem.113(2), 553–562 (2012).
   PubMed Web of Science ®Google Scholar
• Kapoor K , Finer-MooreJS , PedersenBPet al. Mechanism of inhibition of human glucose transporter GLUT1 is conserved between cytochalasin B and phenylalanine amides. Proc. Natl. Acad. Sci. USA113(17), 4711–4716 (2016).
   PubMed Web of Science ®Google Scholar
• Moreira L , AraujoI , CostaTet al. Quercetin and epigallocatechin gallate inhibit glucose uptake and metabolism by breast cancer cells by an estrogen receptor-independent mechanism. Exp. Cell. Res.319(12), 1784–1795 (2013).
   PubMed Web of Science ®Google Scholar
• Brito AF , RibeiroM , AbrantesAMet al. New approach for treatment of primary liver tumors: the role of quercetin. Nutr. Cancer68(2), 250–266 (2016).
   PubMed Web of Science ®Google Scholar
• Azevedo C , Correia-BrancoA , AraujoJR , GuimaraesJT , KeatingE , MartelF. The chemopreventive effect of the dietary compound kaempferol on the MCF-7 human breast cancer cell line is dependent on inhibition of glucose cellular uptake. Nutr. Cancer67(3), 504–513 (2015).
   PubMed Web of Science ®Google Scholar
• Salas M , ObandoP , OjedaLet al. Resolution of the direct interaction with and inhibition of the human GLUT1 hexose transporter by resveratrol from its effect on glucose accumulation. Am. J. Physiol. Cell Physiol.305(1), C90–99 (2013).
   PubMed Web of Science ®Google Scholar
• Wu H , HeL , ShiJet al. Resveratrol inhibits VEGF-induced angiogenesis in human endothelial cells associated with suppression of aerobic glycolysis via modulation of PKM2 nuclear translocation. Clin. Exp. Pharmacol. Physiol.45(12), 1265–1273 (2018).
   PubMed Web of Science ®Google Scholar
• Jung KH , LeeJH , ThienQuach CHet al. Resveratrol suppresses cancer cell glucose uptake by targeting reactive oxygen species-mediated hypoxia-inducible factor-1alpha activation. J. Nucl. Med.54(12), 2161–2167 (2013).
   PubMed Web of Science ®Google Scholar
• Gunnink LK , AlabiOD , KuiperBDet al. Curcumin directly inhibits the transport activity of GLUT1. Biochimie125, 179–185 (2016).
   PubMed Web of Science ®Google Scholar
• Hu Y , LouX , WangRet al. Aspirin, a potential GLUT1 inhibitor in a vascular endothelial cell line. Open Med.14, 552–560 (2019).
   Web of Science ®Google Scholar
• Schimmer AD , ThomasMP , HurrenRet al. Identification of Small Molecules that Sensitize Resistant Tumor Cells to Tumor Necrosis Factor-Family Death Receptors. Cancer Res.66(4), 2367–2375 (2006).
   PubMed Web of Science ®Google Scholar
• Wood TE , DaliliS , SimpsonCDet al. A novel inhibitor of glucose uptake sensitizes cells to FAS-induced cell death. Mol. Cancer Ther.7(11), 3546–3555 (2008).
   PubMed Web of Science ®Google Scholar
• Chan DA , SutphinPD , NguyenPet al. Targeting GLUT1 and the Warburg effect in renal cell carcinoma by chemical synthetic lethality. Sci. Transl. Med.3(94), 94ra70 (2011).
   PubMed Web of Science ®Google Scholar
• Kraus D , ReckenbeilJ , VeitNet al. Targeting glucose transport and the NAD pathway in tumor cells with STF-31: a re-evaluation. Cell. Oncol.41(5), 485–494 (2018).
   Web of Science ®Google Scholar
• Liu Y , CaoY , ZhangWet al. A small-molecule inhibitor of glucose transporter 1 downregulates glycolysis, induces cell-cycle arrest, and inhibits cancer cell growth in vitro and in vivo. Mol. Cancer Ther.11(8), 1672–1682 (2012).
   PubMed Web of Science ®Google Scholar
• Zhang W , LiuY , ChenX , BergmeierSC. Novel inhibitors of basal glucose transport as potential anticancer agents. Bioorg. Med. Chem. Lett.20(7), 2191–2194 (2010).
   PubMed Web of Science ®Google Scholar
• Ojelabi OA , LloydKP , SimonAHet al. WZB117 (2-fluoro-6-(m-hydroxybenzoyloxy) phenyl m-hydroxybenzoate) inhibits GLUT1-mediated sugar transport by binding reversibly at the exofacial sugar binding site. J. Biol. Chem.291(52), 26762–26772 (2016).
   PubMed Web of Science ®Google Scholar
• Siebeneicher H , CleveA , RehwinkelHet al. Identification and optimization of the first highly selective GLUT1 inhibitor BAY-876. ChemMedChem11(20), 2261–2271 (2016).
   PubMed Web of Science ®Google Scholar
• Siebeneicher H , BauserM , BuchmannBet al. Identification of novel GLUT inhibitors. Bioorg. Med. Chem. Lett.26(7), 1732–1737 (2016).
   PubMed Web of Science ®Google Scholar
• Ung PM , SongW , ChengLet al. Inhibitor discovery for the human GLUT1 from homology modeling and virtual screening. ACS Chem. Biol.11(7), 1908–1916 (2016).
   PubMed Web of Science ®Google Scholar
• Reckzeh ES , KarageorgisG , SchwalfenbergMet al. Inhibition of glucose transporters and glutaminase synergistically impairs tumor cell growth. Cell Chem. Biol.26(9), 1214–1228 (2019).
   PubMed Web of Science ®Google Scholar
• Kang SA , O'neillDJ , MachlAWet al. Discovery of small-molecule selective mTORC1 inhibitors via direct inhibition of glucose transporters. Cell Chem. Biol.26(9), 1203–1213 (2019).
   PubMed Web of Science ®Google Scholar
• Karageorgis G , ReckzehES , CeballosJet al. Chromopynones are pseudo natural product glucose uptake inhibitors targeting glucose transporters GLUT-1 and -3. Nat. Chem.10(11), 1103–1111 (2018).
   PubMed Web of Science ®Google Scholar
• Ceballos J , SchwalfenbergM , KarageorgisGet al. Synthesis of indomorphan pseudo-natural product inhibitors of glucose transporters GLUT-1 and -3. Angew Chem. Int. Ed. Engl.58(47), 17016–17025 (2019).
   PubMed Web of Science ®Google Scholar
• Cuppoletti J , MayhewE , JungCY. Cytochalasin B binding to Ehrlich ascites tumor cells and its relationship to glucose carrier. Biochim. Biophys. Acta.642(2), 392–404 (1981).
   PubMedGoogle Scholar
• Nelson KM , DahlinJL , BissonJet al. The essential medicinal chemistry of curcumin. J. Med. Chem.60(5), 1620–1637 (2017).
   PubMed Web of Science ®Google Scholar
• Unlu A , NayirE , DogukanKalenderoglu Met al. Curcumin (turmeric) and cancer. J. Buon.21(5), 1050–1060 (2016).
   PubMed Web of Science ®Google Scholar
• Capodanno D , AngiolilloDJ. Aspirin for primary cardiovascular risk prevention and beyond in diabetes mellitus. Circulation134(20), 1579–1594 (2016).
   PubMed Web of Science ®Google Scholar
• Levine LD , HollandTL , KimKet al. The role of aspirin and inflammation on reproduction: the EAGeR trial. Can. J. Physiol. Pharmacol.97(3), 187–192 (2019).
   PubMed Web of Science ®Google Scholar
• Liu YX , FengJY , SunMMet al. Aspirin inhibits the proliferation of hepatoma cells through controlling GLUT1-mediated glucose metabolism. Acta. Pharmacol. Sin.40(1), 122–132 (2019).
   PubMed Web of Science ®Google Scholar
• Wang T , NingK , LuTX , HuaD. Elevated expression of TrpC5 and GLUT1 is associated with chemoresistance in colorectal cancer. Oncol. Rep.37(2), 1059–1065 (2017).
   PubMed Web of Science ®Google Scholar
• Sawayama H , OgataY , IshimotoTet al. Glucose transporter 1 regulates the proliferation and cisplatin sensitivity of esophageal cancer. Cancer Sci.110(5), 1705–1714 (2019).
   PubMed Web of Science ®Google Scholar